243 related articles for article (PubMed ID: 27192204)
1. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
[No Abstract] [Full Text] [Related]
2. [Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].
Picque JB; Blot M; Binois R; Jeudy G; Simonet AL; Cagnon J; Mahy S; Duong M; Buisson M; Chavanet P; Piroth L
Rev Med Interne; 2012 Feb; 33(2):103-6. PubMed ID: 22236500
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Murray MP; Laurenson IF; Hill AT
Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
[TBL] [Abstract][Full Text] [Related]
4. Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman.
Serra C; Loi G; Saddi B; Pautasso M; Manzin A
J Clin Microbiol; 2007 May; 45(5):1663-5. PubMed ID: 17360837
[TBL] [Abstract][Full Text] [Related]
5. The genetics of nontuberculous mycobacterial infection.
Newport M
Expert Rev Mol Med; 2003 Feb; 5(6):1-13. PubMed ID: 14987409
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
Andréjak C; Lescure FX; Schmit JL; Jounieaux V
Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
[TBL] [Abstract][Full Text] [Related]
7. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?
Levin M; Newport MJ; D'Souza S; Kalabalikis P; Brown IN; Lenicker HM; Agius PV; Davies EG; Thrasher A; Klein N
Lancet; 1995 Jan; 345(8942):79-83. PubMed ID: 7815885
[TBL] [Abstract][Full Text] [Related]
8. Disease caused by non-tuberculous mycobacteria: diagnostic procedures and treatment evaluation in the North of Buenos Aires Province.
Imperiale B; Zumárraga M; Gioffré A; Di Giulio B; Cataldi A; Morcillo N
Rev Argent Microbiol; 2012; 44(1):3-9. PubMed ID: 22610284
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic approach to non-tuberculous mycobacterial infection of the lung.
McGrath EE; Anderson PB
Pulm Pharmacol Ther; 2010 Oct; 23(5):389-96. PubMed ID: 20542128
[TBL] [Abstract][Full Text] [Related]
10. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.
Browne SK; Zaman R; Sampaio EP; Jutivorakool K; Rosen LB; Ding L; Pancholi MJ; Yang LM; Priel DL; Uzel G; Freeman AF; Hayes CE; Baxter R; Cohen SH; Holland SM
Blood; 2012 Apr; 119(17):3933-9. PubMed ID: 22403254
[TBL] [Abstract][Full Text] [Related]
12. Atypical mycobacteria: an important differential for the general physician.
Rahama O; Thaker H
Clin Med (Lond); 2013 Oct; 13(5):504-6. PubMed ID: 24115711
[No Abstract] [Full Text] [Related]
13. Mycobacterium simiae infection in an immunocompetent patient, with DNA analyses verification.
Onen ZP; Karahan ZC; Akkoca Yıldız O; Karabıyıkoğlu G
Tuberk Toraks; 2010; 58(3):306-10. PubMed ID: 21038143
[TBL] [Abstract][Full Text] [Related]
14. An Infant with Cervical Lymphadenitis Secondary to Nontuberculous Mycobacteria Refractory to Conventional Treatment, Responsive to Interferon-Gamma.
Rao A; Piwoz J; Newby K; Sidebottom N; Sacco K
Pediatr Infect Dis J; 2023 Oct; 42(10):e389-e390. PubMed ID: 37343223
[No Abstract] [Full Text] [Related]
15. Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association.
Lim MK; Shim TS; Sheen DH; Na DJ; Min SS; Shim SC
Clin Rheumatol; 2010 Mar; 29(3):335-6. PubMed ID: 20052511
[No Abstract] [Full Text] [Related]
16. Multiple intracellular pathogen infections with ocular pathologies associated with adult-onset immunodeficiency due to anti-interferon-γ autoantibodies: a case report.
Ning Y; Yu Q; Liang H; Wu S; Liang S; Liang X; He Z
BMC Infect Dis; 2024 Jan; 24(1):78. PubMed ID: 38216890
[TBL] [Abstract][Full Text] [Related]
17. Nontuberculous mycobacteria.
Holland SM
Am J Med Sci; 2001 Jan; 321(1):49-55. PubMed ID: 11202480
[TBL] [Abstract][Full Text] [Related]
18. [Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
Zwoliński J; Gałazka J
Pneumonol Alergol Pol; 1992; 60(5-6):70-3. PubMed ID: 1290992
[TBL] [Abstract][Full Text] [Related]
19. [The diagnosis and characteristics of the clinical picture and course of mycobacteriosis].
Sybirna RI; Lytvyn LM; Sybirnyĭ AV; Hrechukha NR; Iukalo VIe
Lik Sprava; 1999; (1):88-90. PubMed ID: 10424010
[TBL] [Abstract][Full Text] [Related]
20. Control of Mycobacterium fortuitum and Mycobacterium intracellulare infections with respect to distinct granuloma formations in livers of BALB/c mice.
Silva TR; Petersen AL; Santos Tde A; Almeida TF; Freitas LA; Veras PS
Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):642-8. PubMed ID: 20835610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
